These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10465549)

  • 21. Non-peptidic HIV protease inhibitors.
    Chrusciel RA; Strohbach JW
    Curr Top Med Chem; 2004; 4(10):1097-114. PubMed ID: 15193141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-based design of HIV protease inhibitors: 4-hydroxycoumarins and 4-hydroxy-2-pyrones as non-peptidic inhibitors.
    Thaisrivongs S; Tomich PK; Watenpaugh KD; Chong KT; Howe WJ; Yang CP; Strohbach JW; Turner SR; McGrath JP; Bohanon MJ
    J Med Chem; 1994 Sep; 37(20):3200-4. PubMed ID: 7932546
    [No Abstract]   [Full Text] [Related]  

  • 23. Dimeric 4-Aryl-1,4-dihydropyridines: development of a third class of nonpeptidic HIV-1 protease inhibitors.
    Hilgeroth A
    Mini Rev Med Chem; 2002 Jun; 2(3):235-45. PubMed ID: 12370065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonpeptidic potent HIV-1 protease inhibitors.
    Prasad JV; Lunney EA; Para KS; Tummino PJ; Ferguson D; Hupe D; Domagala JM; Erickson JW
    Drug Des Discov; 1996 Apr; 13(3-4):15-28. PubMed ID: 8874041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV protease.
    Tait BD; Hagen S; Domagala J; Ellsworth EL; Gajda C; Hamilton HW; Prasad JV; Ferguson D; Graham N; Hupe D; Nouhan C; Tummino PJ; Humblet C; Lunney EA; Pavlovsky A; Rubin J; Gracheck SJ; Baldwin ET; Bhat TN; Erickson JW; Gulnik SV; Liu B
    J Med Chem; 1997 Nov; 40(23):3781-92. PubMed ID: 9371244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of HIV-1 protease inhibitory activity of 4-hydroxy-5,6-dihydropyran-2-ones: QSAR study.
    Ravichandran V; Mourya VK; Agrawal RK
    J Enzyme Inhib Med Chem; 2011 Apr; 26(2):288-94. PubMed ID: 20735159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class.
    Turner SR; Strohbach JW; Tommasi RA; Aristoff PA; Johnson PD; Skulnick HI; Dolak LA; Seest EP; Tomich PK; Bohanon MJ; Horng MM; Lynn JC; Chong KT; Hinshaw RR; Watenpaugh KD; Janakiraman MN; Thaisrivongs S
    J Med Chem; 1998 Aug; 41(18):3467-76. PubMed ID: 9719600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of HIV protease: unique non-peptide active site templates.
    Tait BD; Domagala J; Ellsworth EL; Ferguson D; Gajda C; Hupe D; Lunney EA; Tummino PJ
    J Mol Recognit; 1996; 9(2):139-42. PubMed ID: 8877805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative structure-activity relationships of some HIV-protease inhibitors.
    Gupta SP; Babu MS; Kaw N
    J Enzyme Inhib; 1999; 14(2):109-23. PubMed ID: 10445038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel HIV-protease inhibitors containing beta-hydroxyether and -thioether dipeptide isostere surrogates: modification of the P3 ligand.
    Patel NM; Bennett F; Girijavallabhan VM; Dasmahapatra B; Butkiewicz N; Hart A
    Bioorg Med Chem Lett; 1998 Apr; 8(8):931-4. PubMed ID: 9871514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein structure-based design of potent orally bioavailable, nonpeptide inhibitors of human immunodeficiency virus protease.
    Reich SH; Melnick M; Davies JF; Appelt K; Lewis KK; Fuhry MA; Pino M; Trippe AJ; Nguyen D; Dawson H
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3298-302. PubMed ID: 7724556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2',6'-Dimethylphenoxyacetyl: a new achiral high affinity P(3)-P(2) ligand for peptidomimetic-based HIV protease inhibitors.
    Beaulieu PL; Anderson PC; Cameron DR; Croteau G; Gorys V; Grand-Maître C; Lamarre D; Liard F; Paris W; Plamondon L; Soucy F; Thibeault D; Wernic D; Yoakim C; Pav S; Tong L
    J Med Chem; 2000 Mar; 43(6):1094-108. PubMed ID: 10737742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and activity of novel HIV protease inhibitors with improved potency against multiple PI-resistant viral strains.
    Duffy JL; Kevin NJ; Kirk BA; Chapman KT; Schleif WA; Olsen DB; Stahlhut M; Rutkowski CA; Kuo LC; Jin L; Lin JH; Emini EA; Tata JR
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2423-6. PubMed ID: 12161148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From SAR to comparative QSAR: role of hydrophobicity in the design of 4-hydroxy-5,6-dihydropyran-2-ones HIV-1 protease inhibitors.
    Bhhatarai B; Garg R
    Bioorg Med Chem; 2005 Jun; 13(12):4078-84. PubMed ID: 15911321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles.
    Miller JF; Brieger M; Furfine ES; Hazen RJ; Kaldor I; Reynolds D; Sherrill RG; Spaltenstein A
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3496-500. PubMed ID: 15990305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combinatorial diversification of indinavir: in vivo mixture dosing of an HIV protease inhibitor library.
    Rano TA; Cheng Y; Huening TT; Zhang F; Schleif WA; Gabryelski L; Olsen DB; Kuo LC; Lin JH; Xu X; Olah TV; McLoughlin DA; King R; Chapman KT; Tata JR
    Bioorg Med Chem Lett; 2000 Jul; 10(14):1527-30. PubMed ID: 10915042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of the first N-alkyl cage dimeric 4-aryl-1,4-dihydropyridines as novel nonpeptidic HIV-1 protease inhibitors.
    Hilgeroth A; Wiese M; Billich A
    J Med Chem; 1999 Nov; 42(22):4729-32. PubMed ID: 10579836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From nonpeptide toward noncarbon protease inhibitors: metallacarboranes as specific and potent inhibitors of HIV protease.
    Cígler P; Kozísek M; Rezácová P; Brynda J; Otwinowski Z; Pokorná J; Plesek J; Grüner B; Dolecková-Maresová L; Mása M; Sedlácek J; Bodem J; Kräusslich HG; Král V; Konvalinka J
    Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15394-9. PubMed ID: 16227435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, antiviral activity and pharmacokinetics of P1/P1' substituted 3-aminoindazole cyclic urea HIV protease inhibitors.
    Kaltenbach RF; Patel M; Waltermire RE; Harris GD; Stone BR; Klabe RM; Garber S; Bacheler LT; Cordova BC; Logue K; Wright MR; Erickson-Viitanen S; Trainor GL
    Bioorg Med Chem Lett; 2003 Feb; 13(4):605-8. PubMed ID: 12639540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of potent pyrrolidone-based HIV-1 protease inhibitors with enhanced drug-like properties.
    Kazmierski WM; Andrews W; Furfine E; Spaltenstein A; Wright L
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5689-92. PubMed ID: 15482949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.